TALIS BIOMEDICAL CORP's ticker is TLIS and the CUSIP is 87424L108. A total of 46 filers reported holding TALIS BIOMEDICAL CORP in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Links
Filings
- All filings
- Annual reports (10-K)
- Quarterly reports (10-Q)
- Insider transactions
- Shareholder votes
- Significant ownership
- Events
EDGAR links
External links
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $29,691 | -0.4% | 61,857 | +1.6% | 0.00% | – |
| Q1 2023 | $29,820 | +12.3% | 60,857 | +2.1% | 0.00% | – |
| Q4 2022 | $26,561 | -50.8% | 59,595 | -24.9% | 0.00% | – |
| Q3 2022 | $54,000 | -61.2% | 79,376 | -53.8% | 0.00% | – |
| Q2 2022 | $139,000 | -34.4% | 171,652 | +14.2% | 0.00% | – |
| Q1 2022 | $212,000 | -70.1% | 150,297 | -14.8% | 0.00% | – |
| Q4 2021 | $708,000 | -64.0% | 176,334 | -44.0% | 0.00% | – |
| Q3 2021 | $1,966,000 | -59.7% | 314,614 | -28.9% | 0.00% | -100.0% |
| Q2 2021 | $4,878,000 | +2097.3% | 442,250 | +2458.6% | 0.00% | – |
| Q1 2021 | $222,000 | – | 17,285 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Greenlight Capital | 2,235,783 | $1,095,534 | 0.06% |
| Baker Brothers Advisors | 7,624,835 | $3,736,169 | 0.02% |
| PRELUDE CAPITAL MANAGEMENT, LLC | 223,934 | $109,728 | 0.01% |
| ArrowMark Colorado Holdings LLC | 478,862 | $234,642 | 0.00% |
| WELLS FARGO & COMPANY/MN | 167 | $82 | 0.00% |
| NORTHERN TRUST CORP | 27,860 | $13,652 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| GEODE CAPITAL MANAGEMENT, LLC | 144,416 | $70,763 | 0.00% |
| STATE STREET CORP | 49,536 | $24,273 | 0.00% |
| MILLENNIUM MANAGEMENT LLC | 163,663 | $80 | 0.00% |